Format

Send to

Choose Destination
J Heart Lung Transplant. 2008 Jul;27(7):804-7. doi: 10.1016/j.healun.2008.03.023. Epub 2008 May 19.

Multidrug-resistant Acinetobacter baumannii pneumonia in lung transplant recipients.

Author information

1
Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University Medical Center, Columbus, OH 43210, USA. madhuri.sopirala@osumc.edu

Abstract

We present 6 cases of multidrug-resistant (MDR) Acinetobacter baumannii pneumonia in lung transplant recipients. All cases were treated with imipenem and/or non-traditional antibiotics, such as tigecycline and colistimethate, and had different microbiologic and clinical outcomes. Prior treatment with broad-spectrum anti-microbial therapy was the single most likely risk factor for the development of infection due to MDR Acinetobacter baumannii. Ideal preventive and therapeutic strategies for this pathogen in lung transplant recipients require further study.

PMID:
18582814
DOI:
10.1016/j.healun.2008.03.023
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center